OBSOLETE: Pediatric polyarteritis nodosa Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

Regulatory Watchboard

No FDA or trial events recorded yet for OBSOLETE: Pediatric polyarteritis nodosa.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for OBSOLETE: Pediatric polyarteritis nodosa.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

XARELTO

(RIVAROXABAN)standard

Janssen Pharmaceuticals, Inc.

Factor Xa Inhibitor [EPC]

12.1 Mechanism of Action XARELTO is a selective inhibitor of FXa. It does not require a cofactor (such as Anti-thrombin III) for activity. Rivaroxaban...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for OBSOLETE: Pediatric polyarteritis nodosa.
Search all trials →

Search clinical trials for OBSOLETE: Pediatric polyarteritis nodosa →

Recent News & Research

No recent news articles indexed yet for OBSOLETE: Pediatric polyarteritis nodosa.
Search PubMed for OBSOLETE: Pediatric polyarteritis nodosa →

Browse all OBSOLETE: Pediatric polyarteritis nodosa news →

Specialist Network

No specialists currently listed for OBSOLETE: Pediatric polyarteritis nodosa.

View all OBSOLETE: Pediatric polyarteritis nodosa specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰